~~<i id='F4081CD917'><strike id='F4081CD917'><tt id='F4081CD917'><pre id='F4081CD917'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：focus 2025-09-07 11:14:51 - browse：95

Two Vertex buidings in the Seaport District — David L Ryan/Globe Staff

When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

Now, Vertex may be on the move again.

With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Couple fighting to bring baby home from Mexico are finally reunited

focus

Wikipedia

explore

hotspot

focus

explore

StaffandvolunteersattheHungryMonkfoodpantryprepareanddistributefruitandvegetablestolocalresidentsatt

WSS

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Why health records don't always know when patients are dead

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Couple fighting to bring baby home from Mexico are finally reunited

hotspot

entertainment

focus

How to save PrEP access — and even expand it

Couple fighting to bring baby home from Mexico are finally reunited

Virginia high school admissions case could be legal follow

'Reaching a detente': STAT's Helen Branswell on covering Covid

Jerome Adams on the need for new antivirals for Covid

Norman Reedus' Daryl Dixon

State Dept. review finds Biden bears some blame for Afghanistan failures

Editas, Vertex strike deal on CRISPR

Cancer drug shortages should be causing more outrage

Violet CEO on training clinicians to promote more inclusive care

Wikipedia

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Grail spinoff by Illumina should end disastrous merger attempt

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

TikTok cracks down on users posting about weight loss drugs

Bristol Myers buys into radiopharmaceuticals with RayzeBio

explore

hotspot

focus

explore